Preparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 5, 2011, Pages 351-355

  Gharib, A ^a   Faezizadeh, Z ^a,b   Mohammad Asghari, H ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Amphotricin B; Antifungal activity; Candidiasis; Nanosphere

Indexed keywords

AEROSIL; AMPHOTERICIN B; ANTIBIOTIC AGENT; NANOSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG STABILITY; DRUG SYNTHESIS; ERYTHROCYTE; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRECIPITATION; RABBIT; SPRAY DRYING;

EID: 84455191712     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Falahati M, Shabani M, Rodaki M, Jahaniani F, Porshang Bagheri K, Ebrahimi SA. Interaction between ketoconazole, amphotericin B and terbinafin and three diazenumdiolates in concomitant uses against some fungal species. DARU. 2006; 14: 87-92.
2. Espada R, Valdespina S, Alfonso C, Rivas G, Ballesteros MP. Effect of aggregation state on the toxicity of defferent amphotericin B preparations. Int. J. Pharm. 2008; 361: 64-69.
3. Tiyaboonchai W, Limpeanchob N. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int. J. Pharm. 2007; 329: 142-149.
4. Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm. Res. 2006; 23: 1417-1450.
5. Pestana KC, Formariz TP, Franzini CM, Sarmento VH, Chiavacci LA, Scarpa MV, Egito ES, Oliveira AG. Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B. Colloid Surf. B: Biointerfaces. 2008; 66: 253-259.
6. Amaral AC, Boca AL, Ribeiro AM, Nunes J. Amphotericin B in poly (lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis. J. Anti. Chem. 2009; 63: 529-533.
7. Lemke A, Kiderlen AF, Petri B, Kayser O. Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas. Nanomedicine. 2010; 34: 232-238.
8. Darbandi MA, Rouholamini Najafabadi A, Gilani K, Tajerzadeh H. The effect of vehicles on spray drying of rifampicin inhalable microparticles: In vitro and in vivo evaluation. DARU. 2008; 16: 128-135.
9. Herbrecht R, Natarajan-Ame S, Nivoix Y. The lipid formulations of amphotericin B. Expert Opin. Pharmacother. 2003; 4: 1277-1287.
10. Khandare J, Minko T. Polymer-drug conjugates: progress in polymeric prodrugs. Prog. Polym. Sci. 2006; 31: 359-397.
11. Jung SH, Lim DH, Jung SH, Lee JE, Jeong KS, Seong H, Shin BC. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo Characteristics. Eur. J. Pharm. Sci. 2009; 37: 313-320.
12. Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003; 42: 463-478.
13. Pohlmann AR, Weiss V, Mertins O. Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres development, stability evalution and nanostructure models Eur. Pharm. Sci. 2002; 16: 305-312.
14. Das S, Suresh PK, desmukh R. design of eudragit RL 100 nanoparticles by nanoparticipation method for ocular drug delivery. Nanomedicine. 2010; 6: 318-323.
15. Tamaddon AM, Hosseini-Shirazi F, Moghimi HR. Preparation of oligodeoxynucleotide encapsulated cationic liposomes and release study with models of cellular membranes. DARU. 2007; 15: 61-70.
16. Chakraborty KK, Naik SR. Therapeutic and hemolytic evaluation of in -situ liposomal preparation containing amphotericin B complexed with different chemically modified Beta cyclodextrins. J. Pharm. Sci. 2003; 6: 231-237.
17. National Committee for Clinical Laboratory Standards. References method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved standard NCCLS document M38-A. Wayne (Pa): National Committee for Clinical Laboratory Standards; 2002.
18. Committe on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Commission on Life Sciences National Research Council. Guide for the care and use of laboratory animals. Washington, D.C.: National Academy Press; 1996.
19. Fukui H, Koike T, Saheki A, Sonoke S, Tomii Y, Seki J. Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS). Int. J. Pharm. 2003; 263: 51-60.
20. Espuelas MS, Legrand P, Campanero MA, Appel M, Chéron M, Gamazo C, Barratt G, Irache JM.